Respiratory viral infections: Knowledge based therapeutics

Current Opinion in Immunology

Volumn 24, Issue 4, 2012, Pages 438-443

  Hussell, Tracy ^a   Godlee, Alexandra ^a   Salek Ardakani, Samira ^a   Snelgrove, Robert J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 22; LIVE VACCINE; MEDI 559; PANDERMIX; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA A; INFLUENZA A (H1N1); INNATE IMMUNITY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TREATMENT RESPONSE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION;

ADAPTIVE IMMUNITY; HUMANS; IMMUNITY, INNATE; PATIENT MEDICATION KNOWLEDGE; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84865284824     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.06.001     Document Type: Review

References (48)

1. Singanayagam A., Joshi P.V., Mallia P., Johnston S.L. Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med 2012, 10:27.
2. Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E., Printz M.C., Lee W.M., Shult P.A., Reisdorf E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008, 178:667-672.
3. Thomsen S.F., van der S.S., Stensballe L.G., Posthuma D., Skytthe A., Kyvik K.O., Duffy D.L., Backer V., Bisgaard H. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med 2009, 179:1091-1097.
4. Jackson D.J., Evans M.D., Gangnon R.E., Tisler C.J., Pappas T.E., Lee W.M., Gern J.E., Lemanske R.F. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012, 185:281-285.
5. Goulding J., Godlee A., Vekaria S., Hilty M., Snelgrove R., Hussell T. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J Infect Dis 2011, 204:1086-1094.
6. Vareille M., Kieninger E., Edwards M.R., Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 2011, 24:210-229.
7. Paget C., Ivanov S., Fontaine J., Renneson J., Blanc F., Pichavant M., Dumoutier L., Ryffel B., Renauld J.C., Gosset P., et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem 2012, 287:8816-8829.
8. Nakhaei P., Genin P., Civas A., Hiscott J. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol 2009, 21:215-222.
9. Peiris J.S., Cheung C.Y., Leung C.Y., Nicholls J.M. Innate immune responses to influenza A H5N1: friend or foe?. Trends Immunol 2009, 30:574-584.
10. Teijaro J.R., Walsh K.B., Cahalan S., Fremgen D.M., Roberts E., Scott F., Martinborough E., Peach R., Oldstone M.B., Rosen H. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146:980-991.
11. Snelgrove R.J., Godlee A., Hussell T. Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol 2011, 32:328-334.
12. Hussell T., Goulding J. Structured regulation of inflammation during respiratory viral infection. Lancet Infect Dis 2010, 10:360-366.
13. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G., Doering T.A., Angelosanto J.M., Laidlaw B.J., Yang C.Y., Sathaliyawala T., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054.
14. Paget C., Ivanov S., Fontaine J., Blanc F., Pichavant M., Renneson J., Bialecki E., Pothlichet J., Vendeville C., Barba-Spaeth G., et al. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J Immunol 2011, 186:5590-5602.
15. Chang Y.J., Kim H.Y., Albacker L.A., Lee H.H., Baumgarth N., Akira S., Savage P.B., Endo S., Yamamura T., Maaskant J., et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 2011, 121:57-69.
16. Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., Iwasaki A. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011, 108:5354-5359.
17. Lysholm F., Wetterbom A., Lindau C., Darban H., Bjerkner A., Fahlander K., Lindberg A.M., Persson B., Allander T., Andersson B. Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS ONE 2012, 7:e30875.
18. Lau L.T., Feng X.Y., Lam T.Y., Hui H.K., Yu A.C. Development of multiplex nucleic acid sequence-based amplification for detection of human respiratory tract viruses. J Virol Methods 2010, 168:251-254.
19. Yan Y., Zhang S., Tang Y.W. Molecular assays for the detection and characterization of respiratory viruses. Semin Respir Crit Care Med 2011, 32:512-526.
20. McCullers J.A. Preventing and treating secondary bacterial infections with antiviral agents. Antivir Ther 2011, 16:123-135.
21. Olofsson S., Brittain-Long R., Andersson L.M., Westin J., Lindh M. PCR for detection of respiratory viruses: seasonal variations of virus infections. Expert Rev Anti Infect Ther 2011, 9:615-626.
22. Caliendo A.M. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis 2011, 52(Suppl. 4):S326-S330.
23. Ramilo O., Allman W., Chung W., Mejias A., Ardura M., Glaser C., Wittkowski K.M., Piqueras B., Banchereau J., Palucka A.K., Chaussabel D. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007, 109:2066-2077.
24. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (London) 2010, 466:973-977.
25. Pennings J.L., Schuurhof A., Hodemaekers H.M., Buisman A., de Rond L.C., Widjojoatmodjo M.N., Luytjes W., Kimpen J.L., Bont L., Janssen R. Systemic signature of the lung response to respiratory syncytial virus infection. PLoS ONE 2011, 6:e21461.
26. Kim T.S., Sun J., Braciale T.J. T cell responses during influenza infection: getting and keeping control. Trends Immunol 2011, 32:225-231.
27. Govorkova E.A., McCullers J.A. Therapeutics against influenza. Curr Top Microbiol Immunol 2012, Epub ahead of print.
28. Damjanovic D., Divangahi M., Kugathasan K., Small C.L., Zganiacz A., Brown E.G., Hogaboam C.M., Gauldie J., Xing Z. Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection. Am J Pathol 2011, 179:2963-2976.
29. Karlstrom A., Boyd K.L., English B.K., McCullers J.A. Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis 2009, 199:311-319.
30. Kneyber M.C., van Woensel J.B., Uijtendaal E., Uiterwaal C.S., Kimpen J.L. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Pediatr Pulmonol 2008, 43:142-149.
31. Purcell K., Fergie J. Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 2004, 23:418-423.
32. Berthoud T.K., Hamill M., Lillie P.J., Hwenda L., Collins K.A., Ewer K.J., Milicic A., Poyntz H.C., Lambe T., Fletcher H.A., et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 2011, 52:1-7.
33. Wilkinson T.M., Li C.K., Chui C.S., Huang A.K., Perkins M., Liebner J.C., Lambkin-Williams R., Gilbert A., Oxford J., Nicholas B., et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012, 18:274-280.
34. Nguyen D.T., de W.L., Ludlow M., Yuksel S., Wiesmuller K.H., Geijtenbeek T.B., Osterhaus A.D., De Swart R.L. The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation. PLoS Pathog 2010, 6:e1001049.
35. Goulding J., Tahiliani V., Salek-Ardakani S. OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses. Immunol Rev 2011, 244:149-168.
36. Langley J.M., Aoki F., Ward B.J., McGeer A., Angel J.B., Stiver G., Gorfinkel I., Shu D., White L., Lasko B., et al. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Vaccine 2011, 29:1921-1928.
37. Khan S., Weterings J.J., Britten C.M., de Jong A.R., Graafland D., Melief C.J., van der Burg S.H., van der M.G., Overkleeft H.S., Filippov D.V., Ossendorp F. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells. Mol Immunol 2009, 46:1084-1091.
38. Kirchberger S., Majdic O., Stockl J. Modulation of the immune system by human rhinoviruses. Int Arch Allergy Immunol 2007, 142:1-10.
39. Villar E., Barroso I.M. Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J 2006, 23:5-17.
40. Chang A., Masante C., Buchholz U.J., Dutch R.E. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol 2012, 86:3230-3243.
41. Tayyari F., Marchant D., Moraes T.J., Duan W., Mastrangelo P., Hegele R.G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 2011, 17:1132-1135.
42. Triana-Baltzer G.B., Babizki M., Chan M.C., Wong A.C., Aschenbrenner L.M., Campbell E.R., Li Q.X., Chan R.W., Peiris J.S., Nicholls J.M., Fang F. DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis. J Antimicrob Chemother 2010, 65:275-284.
43. Abed Y., Boivin G. Treatment of respiratory virus infections. Antiviral Res 2006, 70:1-16.
44. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009, 22:240-273. Table.
45. Bao X., Liu T., Shan Y., Li K., Garofalo R.P., Casola A. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 2008, 4:e1000077.
46. Kraus T.A., Garza L., Horvath C.M. Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection. Virology 2008, 371:196-205.
47. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009, 9:271-285.
48. Haworth O., Levy B.D. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007, 30:980-992.